Senior Director, Global Medical Oncology, Pumitamig Breast Cancer Rare Tumors

Working with Us

Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

The Senior Director, Global/US Medical Affairs Oncology, Pumitamig Breast Cancer & other rare tumors, provides scientific and strategic leadership for Pumitamig across breast cancer and other rare tumors within a highly integrated Alliance partnership. Serving as a key therapeutic area expert, this leader delivers medical insights on evolving breast cancer and other rare tumors landscapes and contributes to cross-functional and cross-company scientific, strategic, and tactical discussions.

The role supports the development and implementation of the Global/US Pumitamig Medical Plan, leads or collaborates within Alliance Medical and cross-functional forums which includes the development of Integrated Evidence Plans (IEPs), scientific narratives, publication plans, congress strategies, field medical trainings, and external engagements. The Senior Director will collaborate with the Alliance partners and Medical Evidence Generation teams for the execution of sponsored Medical Affairs GI/GU trials and evaluation of breast cancer and other rare tumors investigator-initiated or collaborative trials.

The role is responsible for the content and execution of Global/US Alliance Breast Cancer and other rare tumors Medical Affairs Advisory Boards. Operating within an Alliance partnership and cross-functional matrix, the Senior Director ensures alignment across organizations and groups and thrives in complexity.

This headquarters-based position reports to the Executive Director, Global/US Medical Affairs Oncology, Pumitamig Medical Product Lead (MPL).

• Scientific and strategic leadership for Pumitamig across breast cancer and other rare tumors within a highly integrated Alliance partnership.
• Provides expert opinion on current trends in pathophysiology, diagnosis, existing and emerging treatment landscape as well as unmet medical needs in breast cancer and other rare tumors to inform key medical and business decisions across the alliance and cross-functionally.
• Co-leads Joint Pumitamig Medical Affairs Team (JMAT), responsible for the development, communication, and execution of the Joint Alliance Global/US Pumitamig Medical Plan, ensuring operational excellence, continuous improvement, and best practice are sharing.
• In collaboration with Global Medical Evidence Generation Team and within the Alliance partnership, develops and executes the integrated evidence generation plan (IEP), including Medical Affairs Pumitamig breast cancer and other rare tumors trials, and evaluation of Pumitamig breast cancer and other rare tumors investigator-initiated or collaborative trials.
• In collaboration with Global Medical Communications Team and within the Alliance partnership, supports delivery of the publication plan, scientific symposia, global independent medical education, scientific narrative/platform and development of all other medical content, as needed.
• Provides ongoing expertise to execute on Pumitamig breast cancer and other rare tumors congress strategy and coordination of joint thought leader engagement plans.
• Leads development of content and execution of Joint Global/US Alliance Pumitamig Breast Cancer and other rare tumors Medical Affairs Advisory Boards.
• Serves as the Medical Affairs representative for Pumitamig Breast Cancer and other rare tumors Clinical Development Teams (CDTs) and provides external insight into the development of study protocols.
• Provides Pumitamig breast cancer and other rare tumors strategic direction to ensure delivery of key knowledge to local medical market colleagues.
• Provides medical support to the Global/US medical affairs organization, including developing and delivering appropriate Pumitamig breast cancer and other rare tumors training curriculum and content for market field medical associates.
• Develops and maintains strong relationships with US/Global breast cancer and other rare tumors thought leaders, key professional organizations in collaboration with other global medical affairs functions and clinical colleagues through scientific dialogue pertinent to breast cancer and other rare tumors landscape.
• Communicates and collaborates with Global Commercialization, Global Drug Development, and Access organizations to integrate breast cancer and other rare tumors medical perspective and external insights into the commercialization process, development plans and ensure appropriate alignment…